Navigation Links
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Date:10/22/2010

Age 18.

Bronchitol was a portable medication, and that was certainly important, because I could go on a trip, and I didn't have to drag along something like the nebulizer.  L. Age 18.

Bronchitol is designed to hydrate the airway surface of the lungs, which can then be cleared more effectively by ciliary clearance and coughing.  It has received Orphan Drug Designation and fast track status from the U.S. Food and Drug Administration and Orphan Drug Designation from the European Medicines Agency.  A marketing application has been submitted and is under review by the EMA.

About Pharmaxis

Pharmaxis (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory disorders.  Its development pipeline of products includes Aridol for the assessment of asthma, Bronchitol for cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease (COPD), PXS25 for the treatment of lung fibrosis and ASM8 and PXS4159 for asthma.  Pharmaxis is listed on the Australian Securities Exchange (symbol PXS).  The company is headquartered in Sydney at its TGA-approved manufacturing facilities.  For more information about Pharmaxis, go to www.pharmaxis.com.au or contact Investor Relations on phone +61 2 9454 7200.

About Bronchitol

Pharmaxis Ltd is developing Bronchitol for the management of chronic obstructive lung diseases including cystic fibrosis, and bronchiectasis.  Bronchitol is a proprietary dry-powder mannitol, precision formulated for delivery to the lungs through an easy-to-use, pocket-size, portable inhaler. Once inhaled its five-way action on mucus helps restore normal lung clearance mechanisms.  Bronchitol has received Orphan Drug Designation and fast track status from the US Food and Drug Administration and Orphan Drug De
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
2. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
3. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
4. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
5. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
6. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
7. Pharmaxis Establishes Named Patient Program for Bronchitol
8. Pharmaxis Long-Term Safety Study of Bronchitol Completes
9. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
10. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
11. Repligen Announces Conference Call of Second Quarter Fiscal Year 2011 Results Tuesday, November 2nd, 3:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... - New Solution That Makes ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" ... yen or $5,000 (without tax /including two pairs of JINS ... a dedicated solution of "JINS MEME" to academic researchers, and ... generated by electrooculography and six-axis sensors without API. (*Physiological data ...
(Date:11/26/2014)... SAN DIEGO , Nov. 26, 2014  Aethlon ... into a definitive agreement to raise approximately $3.3 million ... is being made by one institutional healthcare focused investor. Each ... one-fifth of a common share purchase warrant. Each whole ... at a price of $0.30 for a period of ...
(Date:11/26/2014)... Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... Chairman, Chief Executive Officer and President, will participate in ... at The New York Palace Hotel in ... 11:30 am Eastern Time (ET). To access ... call, go to the  Investor Relations  section of the ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... 4, 2010 /PRNewswire / -- Streamline Health ... provider of document workflow solutions for hospitals, today announced ... delivery systems in the United States, will implement Streamline ... The solution provides an automated ...
... Syringe Locking-Device Technology at HealthAchieve Conference -- JERUSALEM, November 4, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Medicine Technology:Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 2Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 3Texas-Based Hospital Expands Utilization of Streamline Health Document Workflow Solutions 4Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 2Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 3Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 4Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 5Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 6Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 7Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference 8
(Date:11/27/2014)... 27, 2014 An inventor from Buffalo, ... fact of life, and she wants to lessen its ... later, I decided that there needed to be a ... , Easy to use and producible in design variations, ... woman’s private areas throughout the day. It avoids bad ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, ... be safe and produces an immune system response that could ... trial results reported by the U.S. National Institutes of Health. ... the vaccine paves the way for field-testing it in the ... early as January, said Dr. Anthony Fauci, director of the ...
(Date:11/27/2014)... Las Vegas, NV (PRWEB) November 27, 2014 ... Holiday 2014 shopping season has officially launched, Emassagechair.com ... Friday and Cyber Monday Discount Event. , Negotiating ... close relationships with top massage chair brands, Emassagechair.com has ... of their best deals and biggest discounts yet. , ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “LAB.C” was ... which features the latest and coolest technology products available to ... conducted the product review and shared with viewers ... for iOS and Android devices. , Consumers love portability and ... Their Cable Case for the iPhone5 and 5S has ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
Breaking Medicine News(10 mins):Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2
... News) -- New research points to two gene-based methods ... cancers will experience a tumor recurrence. The studies, ... to be presented Wednesday at the 2011 San Antonio ... genetic data gleaned from tumors might help doctors tailor ...
... Medical Center in Cleveland, Ohio is among 65 hospitals ... leader in quality patient care by The Leapfrog Group. ... most competitive national hospital quality award in the country, ... preventing medical errors, reducing mortality for high-risk procedures like ...
... (HealthDay News) -- U.S. officials on Tuesday said that they ... HCG weight loss products from the market. HCG stands ... placenta and found in the urine of pregnant women. The ... diet -- as low as 500 calories per day -- ...
... and commitment to patient-centered medical technology, the University ... have announced the commercial availability of a new ... to diagnose patients with high clarity images at ... an advanced form of spiral x-ray technology that ...
... Ore. The first federally funded report to compare children ... percent to 19 percent of children in the United States ... inadequate to cover the greater scope of care they require ... Care Needs in Context: A Portrait of States and the ...
... , TUESDAY, Dec. 6 (HealthDay News) -- Bed bugs appear ... only ups their "yuck" factor but also enhances the tiny ... from North Carolina State University did a genetic analysis of ... and New Jersey. Their analysis showed the bugs had low ...
Cached Medicine News:Health News:New Tests Might Better Predict Breast Cancer's Return 2Health News:New Tests Might Better Predict Breast Cancer's Return 3Health News:New Tests Might Better Predict Breast Cancer's Return 4Health News:University Hospitals Case Medical Center recognized as national leader by the Leapfrog Group 2Health News:FDA Targets Homeopathic Weight Loss Products 2Health News:FDA Targets Homeopathic Weight Loss Products 3Health News:FDA Targets Homeopathic Weight Loss Products 4Health News:Notre Dame, Purdue and GE Healthcare partner on new CT technology 2Health News:Notre Dame, Purdue and GE Healthcare partner on new CT technology 3Health News:Health care, home, school differ for children with special health care needs 2Health News:Bed Bugs Can Bypass Pitfalls of Inbreeding, Studies Say 2Health News:Bed Bugs Can Bypass Pitfalls of Inbreeding, Studies Say 3
... Hycor Biomedical Ltd Autostat™II Rheumatoid Factor IgM ... Rheumatoid Factor IgM (RF IgM). Enzyme-linked immunosorbent ... specific IgM Rheumatoid Factor in human serum. ... can be used as an aid in ...
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
... Scheimpflug Analyzer is a high precision optical ... analysis of the anterior eye segment, based ... and a Placido Disk. , GALILEI combines ... furnishes high accuracy curvature data, while Scheimpflug ...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w...
Medicine Products: